CDC37L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.342800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.782600E-01
Normal-vs-Stage2
4.066200E-01
Normal-vs-Stage3
3.787800E-02
Normal-vs-Stage4
1.381630E-01
Stage1-vs-Stage2
3.449200E-01
Stage1-vs-Stage3
5.771600E-02
Stage1-vs-Stage4
4.864000E-02
Stage2-vs-Stage3
1.740170E-01
Stage2-vs-Stage4
<1E-12
Stage3-vs-Stage4
4.283300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.314600E-01
Normal-vs-AfricanAmerican
7.478000E-01
Normal-vs-Asian
3.152800E-01
Caucasian-vs-AfricanAmerican
5.822400E-01
Caucasian-vs-Asian
3.483000E-01
AfricanAmerican-vs-Asian
3.791000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.063000E-01
Normal-vs-Female
3.254800E-01
Male-vs-Female
8.529400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.919400E-01
Normal-vs-Age(41-60Yrs)
6.576400E-01
Normal-vs-Age(61-80Yrs)
3.604400E-01
Normal-vs-Age(81-100Yrs)
1.988040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.772000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.761300E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.211600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.659770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.007400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.639360E-01
Normal-vs-Daily Drinker
1.164380E-01
Normal-vs-Weekly Drinker
6.425600E-01
Normal-vs-Occasional Drinker
6.057200E-01
Normal-vs-Social Drinker
4.762000E-01
Non Drinker-vs-Daily Drinker
5.233000E-01
Non Drinker-vs-Weekly Drinker
2.651600E-01
Non Drinker-vs-Occasional Drinker
2.882200E-01
Non Drinker-vs-Social Drinker
2.720200E-01
Daily Drinker-vs-Weekly Drinker
1.527620E-01
Daily Drinker-vs-Occasional Drinker
1.607160E-01
Daily Drinker-vs-Social Drinker
1.335010E-01
Weekly Drinker-vs-Occasional Drinker
9.357400E-01
Weekly Drinker-vs-Social Drinker
8.928200E-01
Occasional Drinker-vs-Social Drinker
9.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.012830E-01
Normal-vs-Grade 2
2.617700E-02
Normal-vs-Grade 3
4.294100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.484100E-02
Grade 1-vs-Grade 3
1.447790E-01
Grade 1-vs-Grade 4
1.012830E-01
Grade 2-vs-Grade 3
8.390600E-01
Grade 2-vs-Grade 4
2.617700E-02
Grade 3-vs-Grade 4
4.294100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.377800E-01
Normal-vs-NonDiabetic
3.021000E-01
Diabetic-vs-NonDiabetic
5.284000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.472800E-01
Normal-vs-NoPancreatitis
3.497000E-01
Pancreatitis-vs-NoPancreatitis
5.523800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.899600E-01
Normal-vs-N1
4.102200E-01
N0-vs-N1
7.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.779400E-01
Normal-vs-TP53-NonMutant
4.913200E-01
TP53-Mutant-vs-TP53-NonMutant
1.838430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
